September 21, 2022 – Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration (FDA) after priority review, approved Elucirem (Gadopiclenol), a new macrocyclic GBCA for use in contrast-enhanced magnetic resonance imaging (MRI). According to a news release

September 20, 2022 — Children and adolescents who have either recovered from COVID-19 or have long COVID show persistent lung damage on MRI, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA). COVID-19 is an infectious disease caused by the

September 16, 2022 — The Radiological Society of North America (RSNA) has announced Technical Exhibits highlights for their 108th Scientific Assembly and Annual Meeting (RSNA 2022) held in Chicago at McCormick Place, Nov. 27 – Dec. 1. As the world’s largest annual medical imaging forum, RSNA 2022

“Lung cancer is the deadliest cancer in men and in women, and it all boils down to how it is detected and when it is diagnosed,” said Michael Wert, MD, director of The James Lung Cancer Screening Clinic at The Ohio State University Wexner Medical Center. Referencing screening programs, like the one

September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to answer cardiac imagers’ questions about SPECT/CT and PET/CT imaging with attenuation correction, localization of radiotracer uptake and coronary artery calcium scoring (CACS). In a